Unknown

Dataset Information

0

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine.

ABSTRACT: In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.

SUBMITTER: Hunsawong T 

PROVIDER: S-EPMC8632161 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The associations between air pollutant exposure and neutralizing antibody titers of an inactivated SARS-CoV-2 vaccine.
| S-EPMC8486374 | biostudies-literature
Unknown Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
| S-EPMC8080482 | biostudies-literature
Unknown Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
| S-EPMC7092874 | biostudies-literature
Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other
Unknown Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.
| S-EPMC8609258 | biostudies-literature
Unknown Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.
| S-EPMC7347890 | biostudies-literature
Unknown A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice.
| S-EPMC7115485 | biostudies-literature
Unknown Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
| S-EPMC8427532 | biostudies-literature
Unknown An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice.
| S-EPMC9181763 | biostudies-literature
Unknown Development of an Inactivated Vaccine against SARS CoV-2.
| S-EPMC8624180 | biostudies-literature